Reuters - Video

Edition: US | UK | IN | CN | JP

video Technology

Modified polio vaccine extends lives in U.S. brain cancer study

Tuesday, June 26, 2018 - 01:02

More than one in five patients with an advanced brain cancer treated with a genetically modified polio vaccine were alive after three years, compared with just 4 percent who received standard treatment, according to U.S. researchers. Stuart McDill reports.

▲ Hide Transcript

View Transcript

More than one in five patients with an advanced brain cancer treated with a genetically modified polio vaccine were alive after three years, compared with just 4 percent who received standard treatment, according to U.S. researchers. Stuart McDill reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Modified polio vaccine extends lives in U.S. brain cancer study

Tuesday, June 26, 2018 - 01:02